TMP-301 / Nxera Pharma, Tempero Bio 
Welcome,         Profile    Billing    Logout  

1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TMP-301 / Tempero Bio
NCT06025396: Multiple Ascending Dose Study of TMP-301 in Healthy Subjects

Completed
1
30
US
TMP-301, Placebo
Tempero Bio, Inc., National Institute on Drug Abuse (NIDA)
Cocaine Use Disorder, Substance Use Disorders, Healthy Volunteers
12/23
01/24

Download Options